Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “PTC THERAPEUTICS, INC.”

149 pharma patents match "PTC THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 149
Index total 30,257
Page 3 / 7

Quick answer

This filtered view shows 149 pharmaceutical patents matching "PTC THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

149 results for “PTC THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 10618877

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    PTC THERAPEUTICS, INC. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  2. US 10584115

    Substituted pyridine and pyrazine BMI-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  3. US 10555960

    Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  4. US 10517853

    Methods for treating epilepsy

    PTC THERAPEUTICS, INC. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted
  5. US 10501482

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted
  6. US 10428050

    Substituted reverse pyrimidine Bmi-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  7. US 10370371

    Substituted pyrimidine Bmi-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  8. US 10300047

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted May 28, 2019 · Expires May 23, 2039

    granted
  9. US 10285980

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted May 14, 2019 · Expires May 9, 2039

    granted
  10. US 10233161

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    PTC THERAPEUTICS, INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  11. US 10195202

    Methods for modulating the amount of RNA transcripts

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted
  12. US 10172836

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy

    PTC THERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  13. US 10071081

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  14. US 10034863

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  15. US 10028939

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted
  16. US 9975878

    Substituted triazine BMI-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  17. US 9969754

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  18. US 9914722

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  19. US 9879007

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  20. US 9877952

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  21. US 9873677

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    PTC THERAPEUTICS, INC. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  22. US 9861617

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  23. US 9737513

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  24. US 9650395

    Antibacterial compounds and methods for use

    PTC THERAPEUTICS, INC. · Granted May 16, 2017 · Expires May 11, 2037

    granted